Aival Masaya
Aival provides independent AI quality assurance software for healthcare, enabling hospitals and AI vendors to evaluate, continuously monitor, and validate clinical AI products using local patient data across the full AI adoption lifecycle.
- Company typePrivate
- Founded2020
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Aival Masaya does
Aival (legally Metalynx LTD) is a London-based, privately-held software company founded in 2020 that provides independent Quality Assurance systems for AI products used in clinical settings. The company sells Aival Analysis Lab, a suite of software installed at hospital sites and healthcare technology platforms that enables healthcare organizations to evaluate, compare, and continuously monitor AI applications from any vendor using their own local patient data. The platform is organized into three modules: Evaluate & Compare (pre-deployment validation of AI products against local population data and radiologist preferences), Monitor (post-deployment surveillance for performance drift, fairness gaps, and unexpected behavior), and Curate (PACS-integrated tooling to build representative test datasets from local clinical data stores). Aival's technology stack combines proprietary methods for AI evaluation (including a peer-reviewed Multimodal Slice Discovery Framework for systematic failure detection in medical image classification, accepted at ISBI 2026) with structured monitoring of prediction outputs and data drift. The platform is integrated into the GE HealthCare ecosystem and has been adopted by NHS trusts including University Hospitals of Leicester, NHS Greater Glasgow and Clyde, and NHS Lothian, with additional use cases supporting AI vendors such as Annalise AI and Harrison.ai for post-market surveillance obligations.
The business model is enterprise software sold primarily through direct field sales to hospitals and NHS health boards, with a complementary OEM channel via the GE HealthCare platform integration. Pricing is quote-based and annual, structured as a recurring subscription, with installation at customer sites for local evaluation and monitoring. Go-to-market is supported by content-driven thought leadership (blog, research publications, case studies), industry event participation (London Tech Week, ISBI 2026, National AI Awards), and regulatory engagement via the RADIANT-CERSI Regulatory Journey Support Project. Aival serves two distinct customer segments: hospitals and healthcare providers seeking to validate AI before procurement and monitor it in clinical use, and AI developers/vendors seeking post-market surveillance tooling and standardized performance reporting across hospital deployments. The company remains an early-stage, founder-led operation (led by CEO Kanwal Bhatia) with 1-10 employees and no disclosed institutional funding.
Aival Masaya firmographics
Firmographics- Name
- Aival Masaya
- Legal name
- Metalynx LTD
- Website
- https://aival.io
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Aival provides independent AI quality assurance software for healthcare, enabling hospitals and AI vendors to evaluate, continuously monitor, and validate clinical AI products using local patient data across the full AI adoption lifecycle.
- Ownership category
- akta.pro rank
Aival Masaya industry classification
Industry- Product category
- Healthcare AI Quality Assurance Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- AI Observability, Monitoring & Evaluation Platforms (Drift, Quality, Safety) (HDAEANAF)
- akta.pro secondary industries
- Regulatory Readiness & Audit Automation (e.g., EU AI Act, NIST AI RMF, ISO/IEC 42001) (HDAAAMAE), Responsible AI, Security & Privacy Platforms (Safety, Guardrails, PII) (HDAEANAG), Medical Imaging AI (HDAAAEAH)
Keywords
Where Aival Masaya is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Aival Masaya business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Revenue model
- Software Licenses: The company provides software solutions (Aival Analysis Lab) installed at customer sites. Based on the enterprise sales motion and 'Request a demo' pricing approach, revenue is generated through software licensing, likely on a subscription or annual contract basis for hospitals and healthcare providers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise pricing for hospitals and healthcare providers |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels5 records
Aival Masaya product offering
Product offeringCore offering
Aival provides a vendor- and platform-neutral software suite called Aival Analysis Lab that is installed at healthcare sites to standardize people and measurement processes for AI assurance. The platform enables hospitals and healthcare providers to independently evaluate and compare AI applications against local patient populations, then continuously monitor their performance post-deployment for safety, fairness, and data drift. It serves NHS trusts, hospital systems, and AI developers in healthcare (particularly radiology and medical imaging) through enterprise software licensing.
Product overview
Aival provides a unified software platform called Aival Analysis Lab for independent Quality Assurance of AI in healthcare settings. The platform consists of three integrated modules: Evaluate & Compare (for pre-deployment validation of AI products against local population data), Monitor (for continuous post-deployment surveillance of AI performance and bias), and Curate (for building representative test datasets via PACS integration). The platform is vendor- and platform-neutral, enabling hospitals to evaluate, compare, and monitor AI solutions from any vendor while minimising clinical workload.
Differentiator
Problem solved
Functional benefit
Brands
- Aival Analysis Lab: Suite of software solutions for evaluating and monitoring AI applications in healthcare settings.
Products and services
- Aival Analysis Lab Vendor- and platform-neutral software suite installed at healthcare sites that standardizes people and measurement processes for AI assurance, enabling independent evaluation and continuous monitoring of AI applications from different vendors while minimizing clinical workload.
- Evaluate & Compare Module Module for validating commercial AI products at healthcare sites through initial product comparison using standardised radiologist and radiographer preferences and technical performance evaluation on local population data.
- Monitor Module Module that ensures AI products in clinical use perform safely over time by alerting users to unexpected changes and supporting post-market surveillance obligations for AI developers.
- Curate Module Module that collects representative test datasets from healthcare sites by integrating with PACS and local data stores, providing full user and dataset management for building evaluation datasets.
Quantifiable outcome
- AI has the potential to reduce lung cancer diagnosis time from 8 weeks to 2 days
Companies that use Aival Masaya
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles2 records
Aival Masaya technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability5 records
Feature5 records
Aival Masaya partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core, flagship and minor.
- University Hospitals of LeicestercoreAival is working with University Hospitals of Leicester (UHL) to ensure the effectiveness of AI (specifically Annalise AI's chest X-ray solution) across all patient groups. Dr Indrajeet Das, Consultant Radiologist at UHL, noted AI's potential to transform the NHS. Will Monaghan, Group Chief Digital Information Officer at UHL, emphasized building confidence in AI use.
- RADIANT-CERSIflagshipAival was chosen as one of six RADIANT-CERSI Regulatory Journey Support Project awardees. RADIANT is a Centre of Excellence in Regulatory Science and Innovation in Transformative Digital Health and AI. Aival brings experience in real-world evaluation and post-market surveillance of AI, contributing to standardizing tools and processes required for safe AI deployment.
- NHS Greater Glasgow and ClydecoreWorking with NHS Greater Glasgow and Clyde to test AI products for suitability on their local population. Dr Mark Hall, Consultant Radiologist at NHS Greater Glasgow and Clyde, provided commentary on the potential of AI and how Aival is helping ensure it works, particularly regarding reducing lung cancer diagnosis time.
- NHS LothiancorePartnership with NHS Lothian as part of work with Health Boards in Scotland to help test AI products for suitability on local populations.
- GE HealthCarecoreAival worked with GE HealthCare and an NHS District General Hospital on a collaborative study to assess third-party AI product suitability. The Aival Analysis Lab was integrated into the GE HealthCare platform, providing a scalable way to evaluate AI products onsite. Jan Beger, Global Head of AI Advocacy at GE HealthCare, noted the importance of local validation in ensuring safety, efficacy, and fairness of AI solutions.
- AI4HealthminorListed as a collaborator in the 'Proudly collaborating with' section on the Aival website.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
Aival Masaya competitors and assessment
Company assessmentDirect peers
- Holistic AI: Holistic AI offers an AI governance, risk, and compliance platform for enterprises deploying AI systems. Overlaps with Aival's regulatory readiness and AI assurance positioning across regulated industries including healthcare.
- Fiddler AI: Fiddler AI provides an AI observability and monitoring platform for production ML models, including drift detection, performance tracking, and explainability. Highly comparable to Aival's Monitor module, with the difference that Fiddler serves multiple industries whereas Aival focuses on healthcare AI assurance.
- WhyLabs: WhyLabs offers an AI observability platform focused on data drift, model performance, and quality monitoring for ML models in production. Comparable to Aival's continuous monitoring and data drift detection features.
- Credo AI: Credo AI provides a Responsible AI governance platform for AI risk assessment, compliance, and audit readiness. Comparable to Aival's responsible AI positioning and regulatory readiness use cases, particularly around EU AI Act preparation.
- Arthur AI: Arthur AI provides an AI observability and performance monitoring platform with model monitoring, bias detection, and explainability features. Closely overlaps with Aival's Evaluate & Compare and Monitor modules for production AI assurance.
- Arize AI: Arize AI offers an AI observability platform for evaluating, monitoring, and troubleshooting ML and LLM applications in production, including drift and performance monitoring. Directly comparable to Aival's continuous monitoring capabilities across healthcare AI deployments.
- Monitaur: Monitaur provides AI governance and model monitoring software with bias testing, performance tracking, and audit trails. Directly comparable to Aival's quality assurance and ongoing monitoring value proposition for AI deployments.
Emerging players
- Tracie AI Solutions: Tracie AI Solutions focuses on AI assurance and validation tooling with overlap to Aival's healthcare AI evaluation niche. An emerging player in the AI assurance space with comparable positioning to Aival's responsible AI focus.
Broad incumbents
- Domino Data Lab: Domino Data Lab offers an enterprise MLOps platform with model lifecycle management, governance, and monitoring capabilities. A broader incumbent in the AI platform space that competes for enterprise healthcare AI tooling budgets, though less specialized in healthcare AI validation than Aival.
- Weights & Biases: Weights & Biases provides an AI developer platform for experiment tracking, model evaluation, and ML observability. A broad incumbent whose model monitoring features partially overlap with Aival's continuous monitoring capabilities, but it is not healthcare-specialized.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Aival Masaya social profiles
Digital presenceAival Masaya compliance and trust
Trust signalCompliance1 record
Aival Masaya financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aival Masaya leadership team
Management profileNumber of profiles
Profiles1 record
Aival Masaya funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aival Masaya M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aival Masaya
What does Aival Masaya do?
Aival provides a vendor- and platform-neutral software suite called Aival Analysis Lab that is installed at healthcare sites to standardize people and measurement processes for AI assurance. The platform enables hospitals and healthcare providers to independently evaluate and compare AI applications against local patient populations, then continuously monitor their performance post-deployment for safety, fairness, and data drift. It serves NHS trusts, hospital systems, and AI developers in healthcare (particularly radiology and medical imaging) through enterprise software licensing.
Is Aival Masaya a public or private company?
Aival Masaya is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Aival Masaya founded?
Aival Masaya was founded in 2020. It employs 1 to 10 people.
Where is Aival Masaya based?
Aival Masaya is headquartered in London, United Kingdom, in the Europe region.
How does Aival Masaya make money?
One revenue line is on record: software Licenses.
Who are Aival Masaya's main competitors?
Direct peers on record are Holistic AI, Fiddler AI, WhyLabs, Credo AI, Arthur AI, Arize AI and Monitaur. Tracie AI Solutions is listed as an emerging player. Broad incumbents are Domino Data Lab and Weights & Biases.
Does Aival Masaya have an API?
No public API is recorded for Aival Masaya.
What industry is Aival Masaya in?
Aival Masaya's product category is Healthcare AI Quality Assurance Software. Its primary akta.pro industry code is HDAEANAF, AI Observability, Monitoring & Evaluation Platforms (Drift, Quality, Safety), with a secondary code of HDAAAMAE, Regulatory Readiness & Audit Automation (e.g., EU AI Act, NIST AI RMF, ISO/IEC 42001). Its NAICS code is 5132 and its SIC code is 7372.